1. Preclinical Studies and Antitumor Mechanism of Action of Luteinizing Hormone-Releasing Hormone Analogues --;2. Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer --;3. Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Breast Cancer --;4. Aromatase Inhibitors as New Endocrine Therapy for Breast Cancer --;5. Clinical Use of Aromatase Inhibitors in the Treatment of Breast Cancer --;6. Aminoglutethimide: Theoretical Considerations and Clinical Results in Advanced Prostate Cancer --;7. Antiestrogen Therapy for Breast Cancer: Current Strategies and Future Prospects --;8. Effects of Estrogens and Antiestrogens on Cell Proliferation: Implications for the Treatment of Breast Cancer --;9. Flutamide and Other Antiandrogens in the Treatment of Advanced Prostatic Carcinoma --;10. Progestational Agents in the Treatment of Breast Cancer.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
The clinical role for other new treatments has not yet been clearly defined, although exciting preliminary data from recent clinical trials are now available. ' Chapters 4, 5, and 6 review the rationale and clinical use of the compounds known collec- tively as the aromatase inhibitors, which can also be used to suppress sex steroid hormone levels.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Medicine.
موضوع مستند نشده
Oncology.
رده بندی کنگره
شماره رده
RC280
.
B8
نشانه اثر
E358
1988
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )